Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)
JOURNAL OF CROHNS & COLITIS, vol.8, no.1, pp.5-18, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Review
- Volume: 8 Issue: 1
- Publication Date: 2014
- Doi Number: 10.1016/j.crohns.2013.04.008
- Journal Name: JOURNAL OF CROHNS & COLITIS
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.5-18
- Keywords: Colorectal cancer, Epidemiology, Chemoprevention, Pathogenesis, Outcomes, PRIMARY SCLEROSING CHOLANGITIS, DOSE URSODEOXYCHOLIC ACID, CHRONIC INTESTINAL INFLAMMATION, COLITIS-ASSOCIATED DYSPLASIA, NF-KAPPA-B, ULCERATIVE-COLITIS, CROHNS-DISEASE, INCREASED RISK, MICROSATELLITE INSTABILITY, 5-AMINOSALICYLIC ACID
- Open Archive Collection: AVESIS Open Access Collection
- Ankara University Affiliated: Yes
Abstract
Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). A detailed literature review was conducted on epidemiology, risk factors, pathophysiology, chemoprevention and outcomes of colorectal cancer (CRC) in IBD as part of the 3rd ECCO scientific pathogenesis workshop. Crown Copyright (C) 2013 Published by Elsevier B.V. on behalf of European Crohn's and Colitis Organisation. All rights reserved.